Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Bile acid receptor | ||
Ligand | BDBM465386 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Binding Assay | ||
EC50 | 63.1±n/a nM | ||
Citation | Chao, J; Jain, R; Hu, L; Lewis, JG; Baribault, H; Caldwell, J Hormone receptor modulators for treating metabolic conditions and disorders US Patent US10793568 Publication Date 10/6/2020 | ||
More Info.: | Get all data from this article, Assay Method | ||
Bile acid receptor | |||
Name: | Bile acid receptor | ||
Synonyms: | BAR | Bile acid receptor FXR | FXR | Farnesol receptor HRR-1 | HRR1 | NR1H4 | NR1H4_HUMAN | Nuclear receptor subfamily 1 group H member 4 | RIP14 | RXR-interacting protein 14 | Retinoid X receptor-interacting protein 14 | farnesoid x receptor | ||
Type: | Nuclear Receptor | ||
Mol. Mass.: | 55916.24 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q96RI1 | ||
Residue: | 486 | ||
Sequence: |
| ||
BDBM465386 | |||
n/a | |||
Name | BDBM465386 | ||
Synonyms: | US10793568, Compound I-5 | ||
Type | Small organic molecule | ||
Emp. Form. | C28H20Cl2F3N3O5S | ||
Mol. Mass. | 638.442 | ||
SMILES | OC(=O)c1cc(c2nc(sc2c1)N1C[C@@H]2C[C@H]1C[C@H]2OC(=O)c1c(onc1-c1c(Cl)cccc1Cl)C1CC1)C(F)(F)F |wU:18.22,14.16,wD:16.17,THB:19:18:13.12:15,8:12:18.17:15,(5.33,1.54,;4,2.31,;4,3.85,;2.67,1.54,;1.33,2.31,;0,1.54,;0,-0,;-1.14,-1.03,;-.52,-2.44,;1.01,-2.28,;1.33,-.77,;2.67,-0,;-1.29,-3.77,;-2.53,-4.12,;-2.21,-5.81,;-3.16,-7.04,;-.91,-5.25,;.59,-5.87,;-.79,-6.16,;-.81,-7.7,;.51,-8.49,;1.85,-7.74,;.49,-10.03,;-.77,-10.92,;-.32,-12.39,;1.22,-12.41,;1.72,-10.95,;3.19,-10.5,;4.32,-11.55,;3.98,-13.05,;5.79,-11.09,;6.13,-9.59,;5,-8.55,;3.53,-9,;2.4,-7.95,;-2.23,-10.42,;-3.74,-10.72,;-3.24,-9.26,;-1.33,2.31,;-2.67,3.08,;-.56,3.64,;-2.1,.98,)| | ||
Structure |